Solo GP: Most New VC Funds Are Built to Fail | Kevin Costa
Solo GP: Most New VC Funds Are Built to Fail | Kevin Costa
YouTube1 hr 27 min
Watch on YouTube
Note: AI-generated summary based on third-party content. Not financial advice. Read more.
Quick Insights
  • The insights do not provide a near-term, high-conviction trade or price target; most private-company opportunities lack the financial and valuation details needed to assess them.
  • Consider QQQ as a public-market alternative to small venture funds only after comparing fees and likely ownership—Costa’s cited 6.5x return has no stated timeframe or assumptions.
  • NVIDIA (NVDA) is mentioned as a potential long-term compounder, but no valuation analysis is provided, so the discussion alone does not establish a buy signal.
Detailed Analysis

ARK (Ukrainian defense company; no ticker stated)

  • ARK develops drones and unmanned ground vehicles for use on Ukraine’s front lines. Costa said its founder’s direct experience there provides unusually strong insight into what military users need.
  • He described the company’s motivation as helping protect people close to the founder, rather than starting a company to raise venture capital.
  • The long-term vision discussed extends beyond defense: Costa sees potential uses for autonomous drones in areas such as agriculture and delivery.
  • Risks raised in the discussion include existential risk from operating in a war zone, dependence on revenue from one geography, and the challenge of scaling sales internationally.

Takeaways

  • The investment case presented rests on frontline product feedback and a broader autonomy vision—not just near-term defense demand.
  • For a company like this, investors would need to assess whether it can survive geopolitical threats and expand beyond its initial market. Costa did not give a price target or timeline.

Surova (personalized cancer vaccines; private company)

  • Costa described Surova as developing personalized cancer vaccines and said he believes disease treatment has substantial room for progress despite growing attention to AI.
  • He cited the founders’ personal motivation to address cancer and said the team had executed well over the prior 12 months.
  • He characterized the company as having strong potential, while noting that it was still early.

Takeaways

  • The discussion points to personalized cancer treatment as a long-term investment theme, but it does not provide clinical results, financial details, or a timeline for commercial success.
  • Costa’s thesis is strongly founder-driven; investors would need additional evidence about the technology and its progress before assessing the opportunity.

Augusta Lab (AI implementation; private company)

  • Augusta Lab works on implementing AI for businesses. Costa said its founder, Rodrigo, believed AI’s economic impact was being underestimated.
  • The company initially spent time as a consulting business implementing AI. Costa said that experience helped it develop capabilities now used for transformation work across large private-equity portfolios.
  • He framed AI as a tool that can make the economy more efficient, while emphasizing that putting AI into practice is challenging.

Takeaways

  • The opportunity discussed is not only building AI models, but helping businesses adopt AI and improve how they operate.
  • Augusta’s early consulting work was presented as a way to build expertise before pursuing larger opportunities. The transcript gives no valuation, revenue figures, or investment timeline.

Superpower (private company)

  • Costa cited Superpower as one of his angel investments. He praised its founder’s strategy of recruiting strong talent from Australia and bringing team members to the United States.
  • He suggested that this approach can help a company build loyalty and retain talent.

Takeaways

  • The discussion highlights talent recruitment and retention as potential sources of advantage for a growing company.
  • No product, financial, or valuation details were provided, so the transcript does not support a more specific investment conclusion.

Deal (private company)

  • Costa cited Deal as an example of a company that grew rapidly, noting that it continued to grow at roughly 10% week over week as its base expanded.
  • He used Deal, alongside Stoke Space, as an example of how observing strong teams can help investors develop a sense for execution and operating pace.

Takeaways

  • Costa’s example emphasizes sustained execution as a signal to watch, rather than relying only on a founder’s pitch.
  • The growth figure was discussed as a historical example, not as a current forecast or investment recommendation.

Stoke Space (private company)

  • Costa cited Stoke Space as an example of a team that shipped products quickly and helped shape his expectations for strong execution.
  • He also said that seeing such companies operate helped him calibrate his standards for founders.

Takeaways

  • The investment insight is about evaluating execution over time—particularly whether teams consistently deliver—not a specific recommendation on Stoke Space.
  • The transcript provides no valuation, financial details, or investment terms.

QQQ (Invesco QQQ Trust)

  • Costa argued that some small venture funds are structurally unattractive when they make many small investments but achieve too little ownership in their winners.
  • In that comparison, he said an investor could put money into QQQ and get 6.5x, without doing the work of investing in startups. He did not specify a timeframe or explain the calculation.

Takeaways

  • Treat the 6.5x figure as Costa’s comparison, not a defined return forecast: the transcript does not state the period or assumptions.
  • The broader point is to compare a venture fund’s fees, ownership, and ability to capture large winners against simpler public-market alternatives.

NVIDIA (NVDA)

  • Costa named NVIDIA as an example of a company that investors would want to hold over long periods because of its ability to compound at scale.
  • He did not discuss NVIDIA’s valuation or make a direct recommendation.

Takeaways

  • NVIDIA was cited as an example of a long-duration compounder, not as a specific buy call.
  • The transcript offers no price target or view on the stock’s current valuation.

Apple (AAPL)

  • Apple was cited alongside NVIDIA and SpaceX as an example of a company that has endured and compounded over a long period.
  • No company-specific analysis or recommendation was given.

Takeaways

  • Costa’s point was that venture returns can depend heavily on backing a small number of companies that endure for decades.
  • This is a general investing framework, not a direct assessment of Apple shares.

Palantir (PLTR)

  • Costa discussed Palantir in the context of founder vision. He said Alex Karp’s conviction in a larger mission helped attract and retain talent through difficult periods.
  • He described Palantir’s work in enterprise data and AI integration as comparatively unglamorous, while emphasizing the importance of how its mission was communicated.

Takeaways

  • The discussion highlights the possible importance of leadership, mission, and talent retention to a company’s long-term prospects.
  • Costa did not offer a valuation view, price target, or recommendation on PLTR.

Microsoft (MSFT)

  • Microsoft was mentioned as an example of a major company whose founder may have been driven by a personal “chip on the shoulder.”
  • It was a founder-motivation example, not an analysis of Microsoft’s business or stock.

Takeaways

  • No actionable company-specific investment thesis was provided for MSFT.

Tesla (TSLA)

  • Tesla was mentioned as an example of the operational challenges that can arise when scaling a company; Costa referred to Valor’s work during Tesla’s “production hell.”
  • The example supported his view that investors can help founders by assisting with practical bottlenecks.

Takeaways

  • The discussion concerns investor support and company operations, not Tesla’s present outlook or stock valuation.
  • No recommendation or price target was stated for TSLA.

SpaceX (private company)

  • Costa cited SpaceX as an example of a company whose future revenue could not necessarily have been modeled from its earlier business.
  • He also used it to illustrate the value of investors providing operational help and supporting a company over time.

Takeaways

  • SpaceX was presented as an example of the uncertainty and long time horizons involved in building a major company.
  • It is a private company, and the transcript provides no valuation or investment terms.

Belief Capital (venture fund)

  • Costa described Belief Capital as a $20 million early-stage fund focused on young technical founders who may be overlooked by conventional venture firms.
  • The fund aims to make concentrated investments, sometimes committing 5%–10% of the fund to a company at the initial stage. Costa said one company represented 20% of the fund on a cost basis.
  • He argued that many small funds risk weak returns by writing small checks across many companies and ending up with little ownership in their eventual winners.
  • His stated approach emphasizes founder resilience, a strong worldview, hiring quality, and shipping velocity. He also said that being helpful to founders can give an investor better information for follow-on decisions.

Takeaways

  • The fund’s approach is a high-conviction, concentrated venture strategy. The discussion suggests evaluating whether its ownership levels and follow-on decisions can compensate for the difficulty of identifying rare breakout companies.
  • Concentration is a prominent feature of the strategy: the transcript states that one position was 20% of the fund on a cost basis. No fund-return target or liquidity timeline was given.

Other company and investment references

  • ElevenLabs (referred to as “11 Labs” in the transcript) was described as a missed opportunity: Costa said he did not take an introductory call. No investment analysis was provided.
  • Forto was mentioned as a company where Costa worked early in his career; it was not discussed as an investment opportunity.
  • Bland, Revolut, Airtable, Miro, Bending Spoons, Valor, Founders Fund, and Sequoia appeared as examples in discussions of company building, venture investing, or acquisitions—not as specific investment recommendations.
  • Costa’s broader theme was that long-term venture outcomes may be driven by a small number of companies that endure for decades. He cautioned against equating fundraising, short-term markups, or deal volume with durable returns.

Takeaways

  • The transcript contains no cryptocurrency recommendation or discussion.
  • Most private-company mentions lack financial, valuation, and market information; the discussion is primarily about founder quality and venture-investing strategy, not near-term security selection.
Ask about this postAnswers are grounded in this post's content.
Video Description
Kevin Costa is the founder and GP of Belief Capital, a $20 million fund backing young technical founders before anyone else will. He started in tech at 17 at Forto, joined La Famiglia (now part of General Catalyst), where he saw Deel and Stoke Space at seed, and has been angel investing his own savings since he was 19. José sits down with Kevin for another episode of the Emerging Managers series on The Delphi Podcast. Kevin explains the two psychological traits he screens for, why he brings his wife to meet founders, and why he thinks most venture screening is intellectually lazy. Then concentration: three schools of follow-on investing, why his first check has to be one he'd grow to 5 to 10% of the fund, why sector-specific funds tend to fail, and why the best young technical founders live on the internet. He walks through Arc, a Ukrainian drone company, a personalized cancer vaccine company, Augusta, an AI implementation firm out of Portugal, and the ElevenLabs call he didn't take. 00:00 Intro 01:21 From Video Games to Venture 03:21 Why a $20M Fund 05:23 Not the Silicon Valley Mold 07:39 The Two Traits He Screens For 13:00 How to Tell the Real Ones 16:18 The Waiter Test 21:32 Venture Is All Psychology 23:32 Calibrating on Greatness 29:08 Do Founders Need Your Help? 34:03 The 10% First Check 39:31 Why Sector Funds Fail 44:54 The Best Founders Live Online 51:49 The Weird Guy in Ukraine 58:05 Two Types of Ambition 59:51 Raising Money Isn't the Point 1:04:24 AGI and No Cure for Cancer 1:08:03 AI Is Ozempic for the Economy 1:11:38 The ElevenLabs Call 1:18:45 Finite and Infinite Games 1:23:51 Building for 50 Years ━━━━━━━━━━━━━━━━━━━━ Follow or get in touch in the comments... José: https://x.com/ZeMariaMacedo Kevin: https://x.com/KevinJDCS Delphi: https://x.com/delphi_digital Delphi Digital: https://delphidigital.io/?utm_source=youtube&utm_medium=video ━━━━━━━━━━━━━━━━━━━━ 🔥WATCH: Most VCs Are Afraid to Be Wrong | Rohan Pujara: https://youtu.be/RL_r5TL3kNg Why the Future of Venture Is Hard Tech, Drones & Physical AI | Ian Rountree: https://youtu.be/pAIrREY_Umk ━━━━━━━━━━━━━━━━━━━━ DISCLOSURE José Maria Macedo is an LP in Belief Capital, and both José and Kevin are investors in Arc. Nothing in this episode is investment advice. ━━━━━━━━━━━━━━━━━━━━ DISCLAIMER The Delphi Podcast (the “Podcast”) is produced by DELPHI MEDIA, LLC (“Delphi Media”). This content is solely for educational and informational purposes and is not, and should not be construed as, legal, tax, investment, or financial advice. Delphi Media is not a financial, tax, or legal advisor. You are expressly advised to consult with a professional advisor before making any investment decisions. Also, the views expressed by Podcast are solely those of hosts and guests do not necessarily reflect those of Delphi Media. Delphi Media is a member of the DELPHI DIGITAL family, a group of distinct companies sharing the same brand and vision. Delphi Ventures operates as an independent venture capital firm that seeks to invest in world-changing founders.
About Delphi Digital
Delphi Digital

Delphi Digital

By @delphi_digital

Your go-to source for in-depth analysis and insights on the broader technology ecosystem.